Effect of Highly Active Antiretroviral Therapy on Viral Burden in the Lungs of HIV‐Infected Subjects
Author(s) -
Homer L. Twigg,
Michael D. Weiden,
Fred Valentine,
Carol SchnizleinBick,
Roland L. Bassett,
Lu Zheng,
Joseph Wheat,
Richard B. Day,
Helen Rominger,
Ronald G. Collman,
Lawrence Fox,
Barbara Brizz,
Joan Dragavon,
Robert W. Coombs,
R. Pat Bucy
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/523766
Subject(s) - bronchoalveolar lavage , viremia , viral load , medicine , peripheral blood mononuclear cell , immunology , cd8 , lung , lymphocyte , lentivirus , virus , viral disease , virology , immune system , biology , in vitro , biochemistry
Human immunodeficiency virus (HIV) is readily detectable in the lungs of infected subjects and leads to an accumulation of CD8(+) lymphocytes in the alveolar space. Although highly active antiretroviral therapy (HAART) is effective in reducing viremia, less is known about its effect on tissue compartments. The AIDS Clinical Trials Group Protocol 723 Team evaluated the effect of HAART on lung viral load and cellular constituents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom